viacyte

ViaCyte generates US$10 million for further stem cell testing

ViaCyte raised US$10 million from private equity investments.

Read Full Article

ViaCyte raises fund to develop diabetes treatment

ViaCyte raised a US$10.6 million from selling Series C-1 Preferred Stock shares.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics